Hôpital de l'hôtel Dieu

Nantes 44000

0 studies enrolling now · 2 studies all time

What they study most

Acute Lymphoblastic Leukemia, Multiple Myeloma

Studies at this site

• A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Patients With Relapse or Refractory Multiple Myeloma — Stopped early
• Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) — Completed